El Senado estatal aprobó unánimemente una legislación que eliminaría los costos compartidos para los exámenes de detección del cáncer de pulmón y las pruebas de seguimiento para las personas elegibles con un seguro médico regulado por el estado, incluido Medicaid.
A statement from John Manna, Jr., Esq., Vice Chair of the American Cancer Society Cancer Action Network Board of Directors and constituent of former U.S. Rep. Nita Lowey, on her passing.
Activistas de la Red de Acción Contra el Cáncer de la Sociedad Americana Contra el Cáncer lamentan la pérdida del Rep. Raúl Grijalva, quien falleció el jueves debido a complicaciones causadas por un cáncer de pulmón.
Today, the American Cancer Society Cancer Action Network (ACS CAN), along with partner organizations, filed an amicus curiae brief with the Supreme Court of the United States (SCOTUS) in the case of Medina v. Planned Parenthood.
Volunteer advocates, including cancer survivors, patients, and caregivers from across Colorado convened at the state capitol for ‘Cancer Action Day’ Wednesday, an event hosted annually by the American Cancer Society Cancer Action Network (ACS CAN). Volunteer advocates met with lawmakers and discussed supporting access to care and sustaining funding for tobacco prevention and cessation.
CHEYENNE, Wyo. –– The Wyoming Legislature closed business last week having again failed to take meaningful action to address the state’s ongoing health care crisis.
SALEM, Oregon —— Jane Leo has been named the American Cancer Society Cancer Action Network (ACS CAN) Government Relations Director for Oregon.
BOISE, Idaho –– The Idaho Senate today ignored the clear will of its constituents and passed House Bill 345, which would strip health care from thousands of hard-working Idahoans and make significant, damaging changes to voter-initiated Medicaid expansion.
Today, the U.S. House passed The Full-Year Continuing Appropriations and Extensions Act, 2025. It contains no increases for federal cancer research or prevention funding and significant cuts to Congressionally Directed Medical Research Programs (CDMRP), in which cancer is the largest recipient of funds.
“With over 2 million people in America expected to be diagnosed with cancer in 2025, now is not the time to halt investments in cancer research, prevention and early detection programs.